Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

OCS stock hub

Oculis Holding AG has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

OCSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.9B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

OCS

In the news

Latest news · OCS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-73.5

P25 -105.6P50 -46.5P75 -3.1

ROIC-37.4

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All OCS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

195

Groups with data

Currency

CHF

Showing 195 of 195 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001953530
Company name	Oculis Holding AG
Country	Switzerland
Country code	US
Employees	60
Employees Change	11%
Employees Change Percent	22.45
Enterprise value	$1.7B
Exchange	NASDAQ
Financial currency	CHF
First seen	2026-05-09
Industry	Biotechnology
Isin	CH1242303498
Last refreshed	2026-05-10
Market cap	$1.9B
Market cap category	Small-Cap
Price	$32.64
Price currency	USD
Rev Per Employee	25,201.25x
Sector	Healthcare
Sic	2834
Symbol	OCS
Website	https://oculis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-6.46%
EV Sales Forward	251.89x
EV/Sales	1,101.52x
FCF yield	-4.44%
P/B ratio	7.65x
P/S ratio	1,277.25x
PS Forward	292.07x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-70.5M
Net Income	$-124.8M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-8,268.81%
Profit Per Employee	$-2.1M
ROA	-28.65
Roa5y	-34.05
ROCE	-41
ROE	-73.45
ROIC	-37.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	77.27%
Cagr3y	36.65%
EPS Growth Quarters	3
EPS Growth Years	3
Revenue Growth	74.78x
Revenue Growth Q	13,600x
Revenue Growth Quarters	1x
Revenue Growth Years	1x
Revenue Growth3 Y	9.55x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.01
Assets	$297.6M
Cash	$268.6M
Current Assets	$281.7M
Current Liabilities	$47.3M
Debt	$2.9M
Debt Equity	$0.01
Equity	$247.3M
Interest Coverage	-98.05
Liabilities	$50.3M
Long Term Assets	$15.8M
Long Term Liabilities	$3M
Net Cash	$265.7M
Net Cash By Market Cap	$13.76
Net Cash Growth	116.14%
Net Debt Equity	$-1.07
Tangible Book Value	$230.5M
Tangible Book Value Per Share	$3.98
WACC	5.38

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.96
Net Working Capital	$-38.3M
Quick ratio	5.85
Working Capital	$229.7M
Working Capital Turnover	$0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-29.29%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	77.2%
200-day SMA	22.42
3Y total return	155.2%
50-day SMA	27.11
50-day SMA vs 200-day SMA	50over200
All Time High	32.76
All Time High Change	-0.37%
All Time High Date	2026-05-08
All Time Low	6.26
All Time Low Change	421.41%
All Time Low Date	2023-03-27
ATR	1.35
Beta	0.2
Beta1y	-0.03
Beta2y	0.35
Ch YTD	63.45
High	32.76
High52	32.76
High52 Date	2026-05-08
High52ch	-0.37%
Low	30.9
Low52	16
Low52 Date	2025-09-02
Low52ch	104%
Ma50ch	20.42%
Premarket Change Percent	1.06
Premarket Price	$31.42
Price vs 200-day SMA	45.58%
RSI	74.16
RSI Monthly	73.83
RSI Weekly	71.86
Sharpe ratio	1.53x
Sortino ratio	2.74
Total Return	-29.29%
Tr YTD	63.45
Tr1m	23.64%
Tr1w	18.78%
Tr3m	14.61%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	6
Analyst Count Top	5
Analyst Price Target Top	$41.6
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.49
Earnings Revenue Estimate	320,000x
Earnings Revenue Estimate Growth	1x
Operating Income	$-103M
Operating margin	-6,811.7
Price target	$42
Price Target Change	$28.68
Price Target Change Top	$27.45

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	49,879,978%
Float Percent	84.3%
Net Borrowing	-480,079.3
Shares Insiders	3.95%
Shares Institutions	27.26%
Shares Out	59,169,475
Shares Qo Q	6.92%
Shares Yo Y	29.29%
Short Float	0.86%
Short Ratio	2.08
Short Shares	0.72

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-106M
Average Volume	444,576.95x
Bv Per Share	4.26
CAPEX	$-379,595
Ch1m	23.64
Ch1w	18.78
Ch1y	77.2
Ch3m	14.61
Ch3y	155.2
Ch6m	69.74
Change	4.99%
Change From Open	5.22
Close	31.09
Days Gap	-0.23
Depreciation Amortization	195,635.5
Dollar Volume	15,828,213.1
Earnings Date	2026-05-22
Earnings Time	amc
EBIT	$-103M
EBITDA	$-102.8M
EPS	$-2.39
F Score	4
FCF	$-85.7M
FCF EV Yield	-5.15x
FCF Per Share	$-1.45
Financing CF	235,724,825
Fiscal Year End	December
Founded	2,003
Income Tax	$-234,567
Investing CF	-76,844,694
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-03
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-04
Ma150	24.05
Ma150ch	35.73%
Ma20	27.94
Ma20ch	16.84%
Net CF	67,622,170
Next Earnings Date	2026-05-22
Open	31.02
Optionable	Yes
Position In Range	93.55
Ppne	3,857,366.3
Pre Close	31.09
Price Date	2026-05-08
Ptbv Ratio	8.38
Relative Volume	1.09x
Revenue	1,512,075x
SBC By Revenue	1,338.12x
Share Based Comp	20,233,306
Tax By Revenue	-15.51x
Tr6m	69.74%
Volume	484,933
Z Score	10.1

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does OCS pay a dividend?

Capital-return profile for this ticker.

Performance

OCS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns OCS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+27.3%

Float: +84.3% of shares outstanding

Insider ownership

+4.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

OCS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

74.2

Above 70: short-term overbought

Price vs 200-day MA

+45.6%

50/200-day relationship not available

Beta (5Y)

0.20

Less volatile than the market

Sharpe ratio

1.53

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About OCS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current OCS stock rating?

Oculis Holding AG is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full OCS analysis?

The full report lives at /stocks/OCS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for OCS?

The latest report frames OCS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the OCS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.